PHK
KYNB

Point72 Hong Kong’s Kyntra Bio KYNB Stock Holding History

Point72 Hong Kong’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-56
Closed -$17K – 2072
2022
Q1 		$17K Buy
+56
New +$19.5K ﹤0.01% 1541
2021
Q4 		– Sell
-253
Closed -$65K – 2045
2021
Q3 		$65K Buy
+253
New +$89.6K ﹤0.01% 1457
2021
Q1 		– Sell
-65
Closed -$60K – 1932
2020
Q4 		$60K Buy
65
+51
+364% +$53.6K ﹤0.01% 1179
2020
Q3 		$14K Sell
14
-1
-7% -$1.08K ﹤0.01% 933
2020
Q2 		$15K Buy
+15
New +$13.9K ﹤0.01% 930
2020
Q1 		– Sell
-9
Closed -$9K – 1076
2019
Q4 		$9K Sell
9
-36
-80% -$36.8K ﹤0.01% 991
2019
Q3 		$42K Buy
+45
New +$49.4K 0.01% 606

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Point72 Hong Kong's KYNB Position: Q2 2022 in Review

Point72 Hong Kong sold out of Kyntra Bio (KYNB) in Q2 2022, closing a stake of 56 shares — an estimated $17K sold.

Point72 Hong Kong first reported a position in KYNB in Q3 2019 and held it in 7 quarters. The position peaked at $65K in Q3 2021. 150 funds tracked by Wall St. Rank hold KYNB as of Q2 2022.

  • Point72 Hong Kong reported no remaining Kyntra Bio position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 56 Kyntra Bio shares in Q2 2022, an estimated $17K.
  • Point72 Hong Kong first reported a position in Kyntra Bio in Q3 2019 and held it in 7 quarters.
  • Point72 Hong Kong's Kyntra Bio position peaked at $65K in Q3 2021.
  • 150 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.